Newsroom

ASGE has joined an AMA-led letter asking the CMS to evaluate its process for incorporating measures into the MIPS and MIPS Value Pathways (MVPs), and to prioritize the value of specialty-led QCDRs.

The Standards of Practice (SOP) Committee has developed a guideline entitled, “ASGE Guideline on endoscopic management of benign and malignant colonic strictures.” The document is available now for review and comment through October 11, 2025.

ASGE hosted its second National Colorectal Cancer (CRC) Screening Summit on September 4 at the ASGE Institute for Training and Technology in Downers Grove, IL.

ASGE is on record  in support of legislation (H.R. 4299) that holds physician reimbursement for Part B drugs harmless from drug price negotiation.

The Senate Appropriations Committee approved its Fiscal Year (FY) 2026 Labor, Health and Human Services, and Education spending bill on July 31 by a vote of 26 to 3.

Reps. Chu and Wilson introduced the Stomach Cancer Prevention and Early Detection Act, directing NCI to review stomach cancer and recommend actions. ASGE supports, noting early detection via endoscopy can improve treatment outcomes.

ASGE joined 60 groups urging HHS OIG to study how Medicare Advantage step therapy for Part B drugs affects care access, citing outdated protocols for IBD and increased use since 2018 guidance.

ACG, AGA, and ASGE previously shared an overview of CMS’ proposed payment rules for 2026. There are two specific proposals within the regulation that have significant implications.

CMS published an alert on fraud schemes targeting Medicare providers that involve bad actors impersonating CMS and sending phishing fax requests for medical records and documentation, falsely claiming to be part of a Medicare audit.